A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer. (Q53377732)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer. |
scientific article |
Statements
A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer. (English)
1 reference
Randolph S Marks
1 reference
David L Graham
1 reference
Jeff A Sloan
1 reference
Shauna Hillman
1 reference
Steven Fishkoff
1 reference
James E Krook
1 reference
Scott H Okuno
1 reference
James A Mailliard
1 reference
Tom R Fitch
1 reference
Ferdinand Addo
1 reference
1 August 2003
1 reference
26
1 reference
4
1 reference
336-337
1 reference
Identifiers
1 reference